CTT Pharmaceutical Valuation
| CTTH Stock | USD 0.1 0.01 7.95% |
CTT Pharmaceutical seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of CTT Pharmaceutical from analyzing the firm fundamentals such as return on equity of -4.49, and Current Valuation of 18.87 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CTT Pharmaceutical's price fluctuation is out of control at this time. Calculation of the real value of CTT Pharmaceutical is based on 3 months time horizon. Increasing CTT Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CTT Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CTT Pink Sheet. However, CTT Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.095 | Real 0.0718 | Hype 0.1 |
The intrinsic value of CTT Pharmaceutical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence CTT Pharmaceutical's stock price.
Estimating the potential upside or downside of CTT Pharmaceutical Holdings helps investors to forecast how CTT pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CTT Pharmaceutical more accurately as focusing exclusively on CTT Pharmaceutical's fundamentals will not take into account other important factors: About CTT Pharmaceutical Valuation
An absolute valuation paradigm, as applied to CTT Pink Sheet, attempts to find the value of CTT Pharmaceutical based on its fundamental and basic technical indicators. By analyzing CTT Pharmaceutical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of CTT Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of CTT Pharmaceutical. We calculate exposure to CTT Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CTT Pharmaceutical's related companies.CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.
8 Steps to conduct CTT Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CTT Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CTT Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CTT Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CTT Pharmaceutical's revenue streams: Identify CTT Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CTT Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CTT Pharmaceutical's growth potential: Evaluate CTT Pharmaceutical's management, business model, and growth potential.
- Determine CTT Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CTT Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for CTT Pink Sheet analysis
When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |